We Pioneered a Technology to Save Millions of Poor Children, But a Worldwide Smear Campaign Has Blocked It

We Pioneered a Technology to Save Millions of Poor Children, But a Worldwide Smear Campaign Has Blocked It

On left, a picture of white rice next to Golden Rice, and on right, a girl who lost one eye due to vitamin A deficiency.

(Photo Credit: Golden Rice Humanitarian Board)


Keep Reading Keep Reading
Adrian Dubock, Ingo Potrykus, Peter Beyer
Peter Beyer headed a research group at University of Freiburg, Germany, with a strong focus on improving the nutritional value of crop plants. Ingo Potrykus worked at ETH Zurich, Switzerland, with a research group using genetic engineering technology applied to "food security" crops in developing countries. Adrian Dubock designed the international collaboration, and its governance, for turning the results of the Potrykus and Beyer teams into a useful product – Golden Rice - to combat vitamin A deficiency, a long-standing objective which all three share. Potrykus is the Chair of the Golden Rice Humanitarian Board, Beyer and Dubock are Board members, and Dubock is also the Executive Secretary of the Board. In common with other Board members, all three are unpaid volunteers.
A new type of cancer therapy is shrinking deadly brain tumors with just one treatment

MRI scans after a new kind of immunotherapy for brain cancer show remarkable progress in one patient just days after the first treatment.

Mass General Hospital

Few cancers are deadlier than glioblastomas—aggressive and lethal tumors that originate in the brain or spinal cord. Five years after diagnosis, less than five percent of glioblastoma patients are still alive—and more often, glioblastoma patients live just 14 months on average after receiving a diagnosis.

But an ongoing clinical trial at Mass General Cancer Center is giving new hope to glioblastoma patients and their families. The trial, called INCIPIENT, is meant to evaluate the effects of a special type of immune cell, called CAR-T cells, on patients with recurrent glioblastoma.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.

Artificial Intelligence is getting better than humans at detecting breast cancer

A recent study in The Lancet Oncology showed that AI found 20 percent more cancers on mammogram screens than radiologists alone.

The Lancet Oncology

Since the early 2000s, AI systems have eliminated more than 1.7 million jobs, and that number will only increase as AI improves. Some research estimates that by 2025, AI will eliminate more than 85 million jobs.

But for all the talk about job security, AI is also proving to be a powerful tool in healthcare—specifically, cancer detection. One recently published study has shown that, remarkably, artificial intelligence was able to detect 20 percent more cancers in imaging scans than radiologists alone.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.